Serum levels of hyaluronan, antigenic keratan sulfate, matrix metalloproteinase 3, and tissue inhibitor of metalloproteinases 1 change predictably in rheumatoid arthritis patients who have begun activity after a night of bed rest

Arthritis and Rheumatism

Volumn 42, Issue 9, 1999, Pages 1861-1869

  Manicourt, Daniel Henri ^a,d   Poilvache, Pascal ^b   Nzeusseu, Adrien ^b   Van Egeren, Anne ^a   Devogelaer, Jean Pierre ^b   Lenz, Mary Ellen ^c   Thonar, Eugene J M A ^c  

^a DE DUVE INSTITUTE   (Belgium)

^b CLINIQUES UNIVERSITAIRES SAINT LUC   (Belgium)

^c RUSH MEDICAL COLLEGE   (United States)

^d UNIVERSITÉ CATHOLIQUE DE LOUVAIN   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

HYALURONIC ACID; KERATAN SULFATE; MATRIX METALLOPROTEINASE; METALLOPROTEINASE INHIBITOR; STROMELYSIN;

ADULT; ARTICLE; BED REST; BLOOD SAMPLING; CLINICAL ARTICLE; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; MALE; PHYSICAL ACTIVITY; PRIORITY JOURNAL; RHEUMATOID ARTHRITIS;

ADULT; ANTIGENS; ARTHRITIS, RHEUMATOID; BED REST; BIOLOGICAL MARKERS; EXERCISE; FEMALE; HUMANS; HYALURONIC ACID; KERATAN SULFATE; KIDNEY FUNCTION TESTS; LIVER FUNCTION TESTS; MALE; MATRIX METALLOPROTEINASE 3; MIDDLE AGED; TIME FACTORS; TISSUE INHIBITOR OF METALLOPROTEINASE-1;

EID: 0033501681     PISSN: 00043591     EISSN: None     Source Type: Journal    
DOI: 10.1002/1529-0131(199909)42:9<1861::AID-ANR10>3.0.CO;2-I     Document Type: Article

References (35)

1. Billinghurst RC, Dahlberg L, Ionescu M, Reiner A, Bourne R, Rorabeck C, et al. Enhanced cleavage of type II collagen by collagenases in osteoarthritic articular cartilage. J Clin Invest 1997;99:1534-45.
2. Lark MW, Bayne EK, Flanagan J, Harper CF, Hoerrner LA, Hutchinson NI, et al. Aggrecan degradation in human cartilage: evidence for both matrix metalloproteinase and aggrecanase activity in normal, osteoarthritic and rheumatoid joints. J Clin Invest 1997;100:93-106.
3. Poole AR, Alini M, Hollander AP. Cellular biology of cartilage degradation. In: Henderson B, Edwards JCW, Pettigher ER, editors. Mechanisms and models in rheumatoid arthritis. London: Academic Press; 1995. p. 163-204.
4. Walakovits LA, Moore VL, Bhardwaj N, Gallick GS, Lark MW. Detection of stromelysin and collagenase in synovial fluid from patients with rheumatoid arthritis and posttraumatic knee injury. Arthritis Rheum 1992;35:35-42.
5. Sasaki S, Iwata H, Ishiguro N, Obata K, Miura T. Detection of stromelysin in synovial fluid and serum from patients with rheumatoid arthritis and osteoarthritis. Clin Rheumatol 1994;13:228-33.
6. Thonar EJ-MA, Lenz ME, Klintworth GK, Caterson B, Pachman LM. Glickman P, et al. Quantification of keratan sulfate in blood as a marker of cartilage metabolism. Arthritis Rheum 1985;28: 1367-76.
7. Saxne T, Heinegard D, Wollheim FA. Therapeutic effects on cartilage metabolism in arthritis as measured by the release of proteoglycan structures into the synovial fluid. Ann Rheum Dis 1986;45:492-7.
8. Witter J, Roughley PJ, Webber C, Roberts N, Keystone E, Poole AR. The immunologic detection and characterization of cartilage proteoglycan degradation products in synovial fluids of patients with arthritis. Arthritis Rheum 1987;30:519-29.
9. Ratcliffe A, Doherty M, Maini RN, Hardingham TE. Increased concentrations of proteoglycan components in the synovial fluid of patients with acute but not chronic joint disease. Ann Rheum Dis 1988;47:826-32.
10. Lohmander LS, Dahlberg L, Ryd L, Heinegård D. Increased levels of proteoglycan fragments in knee joint fluid after injury. Arthritis Rheum 1989;32:1434-42.
11. Saxne T, Heinegård D, Wollheim FA, Pettersson H. Differences in cartilage proteoglycan level in synovial fluid in early rheumatoid arthritis and reactive arthritis. Lancet 1985;1:127-8.
12. Manicourt D-H, Fujimoto N, Obata K, Thonar EJ-MA. Levels of circulating collagenase, stromelysin-1, and tissue inhibitor of matrix metalloproteinases 1 in patients with rheumatoid arthritis: relationship to the serum levels of antigenic keratan sulfate and systemic parameters of inflammation. Arthritis Rheum 1995;38: 1031-9.
13. Poole AR, Witter J, Roberts N, Piccolo F, Brandt R, Paquin J, et al. Inflammation and cartilage metabolism in rheumatoid arthritis: studies of the blood markers hyaluronic acid, orosomucoid, and keratan sulfate. Arthritis Rheum 1990;33:790-9.
14. Manicourt D-H, Triki R, Fukuda K, Devogelaer J-P, Nagant de Deuxchaisnes C, Thonar EJ-MA. Levels of circulating tumor necrosis factor α and interleukin-6 in patients with rheumatoid arthritis: relationship to serum levels of hyaluronan and antigenic keratan sulfate. Arthritis Rheum 1993;36:490-9.
15. Mehrahan F, Finegan CK, Moskowitz RW. Serum keratan sulfate: quantitative and qualitative comparisons in inflammatory versus noninflammatory arthritides. Arthritis Rheum 1991;34:383-92.
16. Hamerman D, Wood DD. Interleukin-1 enhances synovial cell hyaluronate synthesis. Proc Soc Exp Biol Med 1984;177:205-10.
17. Butler DM, Vitti GF, Leizer T, Hamilton JA. Stimulation of the hyaluronic acid levels of human synovial fibroblasts by recombinant human tumor necrosis factor a, tumor necrosis factor β (lymphotoxin), interleukin-1α, and interleukin-1β. Arthritis Rheum 1988;31:1281-9.
18. Engström-Laurent A, Hallgren R. Circulating hyaluronate in rheumatoid arthritis: relationship to inflammatory activity and the effect of corticosteroid therapy. Ann Rheum Dis 1985;44:83-8.
19. Paimela L, Heiskanen A, Kurki P, Helve T, Leirisalo-Repo M. Serum hyaluronate level as a predictor of radiologic progression in early rheumatoid arthritis. Arthritis Rheum 1991;34:815-21.
20. Manicourt D-H, Fujimoto N, Obata K, Thonar EJ-MA. Serum levels of collagenase, stromelysin-1, and TIMP-1: age- and sex-related differences in normal subjects and relationship to the extent of joint involvement and serum levels of antigenic keratan sulfate in patients with osteoarthritis. Arthritis Rheum 1994;37: 1774-83.
21. Engström-Laurent A, Hallgren R. Circulating hyaluronic acid levels vary with physical activity in healthy subjects and in rheumatoid arthritis patients: relationship to synovitis mass and morning stiffness. Arthritis Rheum 1987;30:1333-8.
22. Committee of the American Rheumatism Association. 1958 revision of diagnostic criteria for rheumatoid arthritis. Arthritis Rheum 1959;2:16-20.
23. Lansbury J. Quantitation of activity of rheumatoid arthritis: method for summation of systemic indices of rheumatoid activity. Am J Med Sci 1956;232:300-17.
24. Obata K, Iwata K, Okada Y, Kohrin Y, Ohuchi E, Yoshida S, et al. A one-step sandwich enzyme immunoassay for human matrix metalloproteinase 3 (stromelysin-1) using monoclonal antibodies. Clin Chim Acta 1992;211:59-72.
25. Kodama S, Iwata K, Iwata H, Yamashita K, Hayakawa T. Rapid one-step sandwich enzyme immunoassay for tissue inhibitor of metalloproteinases: an application for rheumatoid arthritis serum and plasma. J Immunol Methods 1990;127:103-8.
26. Saxne T, Hayford J, Heinegård D, Lenz ME, Thonar E, Wollheim FA, et al. Serum levels of the proteoglycan core protein and keratan sulfate correlate in juvenile rheumatoid arthritis [abstract]. Arthritis Rheum 1989;32 Suppl 4:S105.
27. Li XQ, Thonar EJMA, Knudson W. Accumulation of hyaluronate in human lung carcinoma as measured by a new hyaluronate ELISA. Connect Tissue Res 1989;19:243-53.
28. Konttinen YT, Saari H, Honkanen VE, Szocsik K, Mussalo-Rauhamaa H, Tulensalo R, et al. Serum baseline hyaluronate and disease activity in rheumatoid arthritis. Clin Chim Acta 1990;193: 39-47.
29. Saari H, Kontinnen YT, Nordstrom D. Effect of joint mobilization on serum hyaluronate. Ann Med 1991;23:29-32.
30. MacNaul KL, Chartrain N, Lark M, Tocci MJ, Hutchinson NI. Discoordinate expression of stromelysin, collagenase and tissue inhibitor of metalloproteinase-1 in rheumatoid synovial fibroblasts: synergistic effects of interleukin-1 and tumor necrosis factor-α on stromelysin expression. J Biol Chem 1990;265:17238-45.
31. 2 release from cartilage in organ culture. Arthritis Rheum 1989;32:288-97.
32. Page-Thomas DP, Bard D, King B, Dingle JT. Clearance of proteoglycans from joint cavities. Ann Rheum Dis 1987;46:934-7.
33. Sweet MBE, Jakim I, Coelho A, Becker PJ, Thonar EJ-MA. Serum keratan sulfate levels in marathon runners. Int J Sports Med 1992;13:348-50.
34. Roos H, Dahlberg L, Hoerrner LA, Lark MW, Thonar EJ-MA, Shinmei M, et al. Markers of cartilage matrix in human joint fluid and serum: the effect of exercise. Osteoarthritis Cartilage 1995;3: 7-14.
35. Sweet MBE, Jakim I, Coelho A, Becker PJ, Thonar EJ-MA. Serum keratan sulphate levels during prolonged rest. S Afr Med J 1990;78:629-30.